Evidence map›Paper›PMID 27853168›Full record

ArticleInternational journal of impotence research2017

Depressive symptoms and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: the Dogo Study.

S Furukawa, T Sakai, T Niiya, H Miyaoka, T Miyake, S Yamamoto, K Maruyama, T Ueda, H Senba, M Torisu and 6 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in International journal of impotence research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 1 country.

S FurukawaDepartment of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine, Toon, Japan.
T SakaiDepartment of Internal Medicine, Yawatahama General City Hospital, Yawatahama, Japan.
T NiiyaDepartment of Internal Medicine, Matsuyama Shimin Hospital, Matsuyama, Japan.
H MiyaokaDepartment of Internal Medicine, Saiseikai Matsuyama Hospital, Matsuyama, Japan.
T MiyakeDepartment of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan.
S YamamotoDepartment of Lifestyle-related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Toon, Japan.
K MaruyamaDepartment of Public Health, Juntendo University School of Medicine, Bunkyo, Japan.
T UedaDepartment of Internal Medicine, Ehime Prefectural Central Hospital, Matuayama, Japan.
H SenbaDepartment of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine, Toon, Japan.
M TorisuDepartment of Internal Medicine, Saiseikai Saijo Hospital, Saijo, Japan.
H MinamiDepartment of Internal Medicine, Ehime Niihama Hospital, Niihama, Japan.
M OnjiDepartment of Internal Medicine, Saiseikai Imabari Hospital, Imabari, Japan.
T TanigawaDepartment of Public Health, Juntendo University School of Medicine, Bunkyo, Japan.
B MatsuuraDepartment of Lifestyle-related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Toon, Japan.
Y HiasaDepartment of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan.
Y MiyakeDepartment of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine, Toon, Japan.
Ehime University · JPJuntendo University · JPEhime Medical Center · JPEhime Prefectural Central Hospital · JPMatsuyama Shimin Hospital · JPMeijo Hospital · JPNational Institute of Technology, Niihama College · JPSaiseikai Ibaraki Hospital · JPSaiseikai Matsuyama Hospital · JPYawata Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In several studies of patients with type 2 diabetes mellitus, a positive association between depressive symptoms and erectile dysfunction (ED) has been reported. No evidence exists, however, regarding the association between depressive symptoms and ED among Japanese patients with type 2 diabetes mellitus. Thus, we examined this issue among Japanese patients with type 2 diabetes mellitus. Study subjects were 469 male Japanese patients with type 2 diabetes mellitus, aged 19 years or over. ED, moderate to severe ED and severe ED were defined as present when a subject had a Sexual Health Inventory for Men score <22, <12 and <8, respectively. Depressive symptoms were defined as present when a subject had a Self-Rating Depression Scale (SDS) score >49. Adjustment was made for age, body mass index, waist, duration of type 2 diabetes, current smoking, current drinking, hypertension, dyslipidemia, coronary artery disease, stroke, glycated hemoglobin and diabetic neuropathy. The prevalence values of depressive symptoms, moderate to severe ED and severe ED were 15.1%, 64.2% and 51.0%, respectively. Depressive symptoms were independently positively associated with moderate to severe ED and severe ED (adjusted odds ratios were 2.23 (95% confidence interval (CI): 1.17-4.43) and 1.86 (95% CI: 1.04-3.41), respectively). In Japanese patients with type 2 diabetes mellitus, depressive symptoms may be associated with ED.

Indexed as

AgedDepressionDiabetes Mellitus, Type 2Erectile DysfunctionHumansJapanLogistic ModelsMaleMiddle AgedProspective StudiesPsychiatric Status Rating ScalesRisk FactorsSeverity of Illness IndexSurveys and Questionnaires

Identifiers

PMID27853168
OpenAlexW2551984705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.